Endoscopistsʼ diagnostic accuracy in detecting upper gastrointestinal neoplasia in the framework of artificial intelligence studies

Abstract

Background Estimates on miss rates for upper gastrointestinal neoplasia (UGIN) rely on registry data or old studies. Quality assurance programs for upper GI endoscopy are not fully established owing to the lack of infrastructure to measure endoscopists’ competence. We aimed to assess endoscopists’ accuracy for the recognition of UGIN exploiting the framework of artificial intelligence (AI) validation studies.

Methods Literature searches of databases (PubMed/MEDLINE, EMBASE, Scopus) up to August 2020 were performed to identify articles evaluating the accuracy of individual endoscopists for the recognition of UGIN within studies validating AI against a histologically verified expert-annotated ground-truth. The main outcomes were endoscopists’ pooled sensitivity, specificity, positive and negative predictive value (PPV/NPV), and area under the curve (AUC) for all UGIN, for esophageal squamous cell neoplasia (ESCN), Barrett esophagus-related neoplasia (BERN), and gastric adenocarcinoma (GAC).

Results Seven studies (2 ESCN, 3 BERN, 1 GAC, 1 UGIN overall) with 122 endoscopists were included. The pooled endoscopists’ sensitivity and specificity for UGIN were 82 % (95 % confidence interval [CI] 80 %–84 %) and 79 % (95 %CI 76 %–81 %), respectively. Endoscopists’ accuracy was higher for GAC detection (AUC 0.95 [95 %CI 0.93–0.98]) than for ESCN (AUC 0.90 [95 %CI 0.88–0.92]) and BERN detection (AUC 0.86 [95 %CI 0.84–0.88]). Sensitivity was higher for Eastern vs. Western endoscopists (87 % [95 %CI 84 %–89 %] vs. 75 % [95 %CI 72 %–78 %]), and for expert vs. non-expert endoscopists (85 % [95 %CI 83 %–87 %] vs. 71 % [95 %CI 67 %–75 %]).

Conclusion We show suboptimal accuracy of endoscopists for the recognition of UGIN even within a framework that included a higher prevalence and disease awareness. Future AI validation studies represent a framework to assess endoscopist competence.

^* Joint first authors

Publikationsverlauf

Eingereicht: 05. Januar 2021

Angenommen nach Revision: 05. Mai 2021

Accepted Manuscript online:
05. Mai 2021

Artikel online veröffentlicht:
17. Juni 2021

• References

• 1 Arnold M, Abnet CC, Neale RE. et al. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology 2020; 159: 335-349.e15
• 2 Pimentel-Nunes P, Libânio D, Marcos-Pinto R. et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy 2019; 51: 365-388
• 3 Areia M, Spaander MC, Kuipers EJ. et al. Endoscopic screening for gastric cancer: A cost-utility analysis for countries with an intermediate gastric cancer risk. United European Gastroenterol J 2018; 6: 192-202
• 4 Areia M, Carvalho R, Cadime AT. et al. Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies. Helicobacter 2013; 18: 325-337
• 5 di Pietro M, Chan D, Fitzgerald RC. et al. Screening for Barrett’s esophagus. Gastroenterology 2015; 148: 912-923
• 6 Săftoiu A, Hassan C, Areia M. et al. Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy 2020; 52: 293-304
• 7 Pimenta-Melo AR, Monteiro-Soares M, Libânio D. et al. Missing rate for gastric cancer during upper gastrointestinal endoscopy: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2016; 28: 1041-1049
• 8 Hernanz N, Rodríguez de Santiago E, Marcos Prieto HM. et al. Characteristics and consequences of missed gastric cancer: A multicentric cohort study. Dig Liver Dis 2019; 51: 894-900
• 9 Rodríguez de Santiago E, Hernanz N, Marcos-Prieto HM. et al. Rate of missed oesophageal cancer at routine endoscopy and survival outcomes: A multicentric cohort study. United European Gastroenterol J 2019; 7: 189-198
• 10 Kaminski MF, Thomas-Gibson S, Bugajski M. et al. Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy 2017; 49: 378-397
• 11 van der Sommen F, de Groof J, Struyvenberg M. et al. Machine learning in GI endoscopy: practical guidance in how to interpret a novel field. Gut 2020; 69: 2035-2045
• 12 Arribas J, Antonelli G, Frazzoni L. et al. Standalone performance of artificial intelligence for upper GI neoplasia: a meta-analysis. Gut 2020;
• 13 Bisschops R, Areia M, Coron E. et al. Performance measures for upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy 2016; 48: 843-864
• 14 Moher D, Liberati A, Tetzlaff J. et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009; 62: 1006-1012
• 15 Whiting PF, Rutjes AWS, Westwood ME. et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011; 155: 529-536
• 16 Reitsma JB, Glas AS, Rutjes AWS. et al. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 2005; 58: 982-990
• 17 Naaktgeboren CA, Ochodo EA, Van Enst WA. et al. Assessing variability in results in systematic reviews of diagnostic studies. BMC Med Res Methodol 2016; 16: 6
• 18 Doebler P, Holling H. Meta-analysis of diagnostic accuracy with mada. https://rdrr.io/rforge/mada/f/inst/doc/mada.pdf Accessed: 7 May 2021.
• 19 R: a language and environment for statistical computing. https://www.gbif.org/tool/81287/r-a-language-and-environment-for-statistical-computing Accessed: 7 May 2021.
• 20 Horiuchi Y, Aoyama K, Tokai Y. et al. Convolutional neural network for differentiating gastric cancer from gastritis using magnified endoscopy with narrow band imaging. Dig Dis Sci 2020; 65: 1355-1363
• 21 Ikenoyama Y, Hirasawa T, Ishioka M. et al. Detecting early gastric cancer: Comparison between the diagnostic ability of convolutional neural networks and endoscopists. Dig Endosc 2021; 33: 141-150
• 22 Cai S-L, Li B, Tan W-M. et al. Using a deep learning system in endoscopy for screening of early esophageal squamous cell carcinoma (with video). Gastrointest Endosc 2019; 90: 745-753.e2
• 23 Ohmori M, Ishihara R, Aoyama K. et al. Endoscopic detection and differentiation of esophageal lesions using a deep neural network. Gastrointest Endosc 2020; 91: 301-309.e1
• 24 Fukuda H, Ishihara R, Kato Y. et al. Comparison of performances of artificial intelligence versus expert endoscopists for real-time assisted diagnosis of esophageal squamous cell carcinoma (with video). Gastrointest Endosc 2020; 92: 848-855
• 25 Ebigbo A, Mendel R, Probst A. et al. Computer-aided diagnosis using deep learning in the evaluation of early oesophageal adenocarcinoma. Gut 2019; 68: 1143-1145
• 26 de Groof AJ, Struyvenberg MR, van der Putten J. et al. Deep-learning system detects neoplasia in patients with Barrett’s esophagus with higher accuracy than endoscopists in a multistep training and validation study with benchmarking. Gastroenterology 2020; 158: 915-929.e4
• 27 van der Sommen F, Zinger S, Curvers W. et al. Computer-aided detection of early neoplastic lesions in Barrett’s esophagus. Endoscopy 2016; 48: 617-624
• 28 Wu L, Zhou W, Wan X. et al. A deep neural network improves endoscopic detection of early gastric cancer without blind spots. Endoscopy 2019; 51: 522-531
• 29 Luo H, Xu G, Li C. et al. Real-time artificial intelligence for detection of upper gastrointestinal cancer by endoscopy: a multicentre, case-control, diagnostic study. Lancet Oncol 2019; 20: 1645-1654
• 30 Uedo N, Gotoda T, Yoshinaga S. et al. Differences in routine esophagogastroduodenoscopy between Japanese and international facilities: A questionnaire survey. Dig Endosc 2016; 28: 16-24